Trial intelligence / Profile preview

DECO-SSI: Preoperative Decolonization in Orthopaedic Surgery

NCT03962907Phase 4Completed

Sponsor
Lindenhofgruppe
Start
Jan 2019
Primary completion
Mar 2020
Modality
Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
Countries
1
01

Overview

A Phase 4 trial of mupirocin, chlorhexidine in surgical site infection (SSI), sponsored by Lindenhofgruppe. Started Jan 2019; status: completed.

02

Drugs

mupirocinchlorhexidine
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on NCT03962907.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03962907.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call